AASLD Guideline: Long-Term Care for Pediatric Liver Transplantation

Guidelines for the long-term care of pediatric liver transplantation have been published (Liver Transplantation 2013; 19: 798-625). At the time of this writing, it has not been uploaded to the AASLD website which archives a large number of guidelines related to liver disorders (AASLD: Practice Guidelines).

Due to the extensive nature of the guidelines, I will not try to summarize them, though I think having this reference is useful.  To see how familiar you are with current recommendations, you may want to take the following quiz:

1. Which of the following are not part of routine liver transplantation care, according to the authors?

  • a. Assessment of school functioning
  • b. Assessment for hearing loss
  • c. Protocol liver biopsy at 1 year
  • d. Resumption of full physical activity by 12 weeks after LT

2. Which of these vaccines should be given (if age appropriate) before LT but not afterwards?

  • a. Measles, Mumps, Rubella
  • b. Varicella
  • c. Rotavirus
  • d. Human papillomavirus

3. True/False: Tattoos and piercings are acceptable if the child has received the hepatitis B vaccine.

4. Options for treating chronic rejection, which is a major cause of late graft loss, include all of the following except:

  • a. Give rituximab
  • b. Switch to mycophenolate
  • c. Switch to rapamycin
  • d. Higher doses of tacrolimus

5. Target level for tacrolimus trough for patients more than 1 year after transplantation?

  • a. 10-12 ng/mL
  • b. <10 ng/mL
  • c. 8-10 ng/mL
  • d. <8 ng/mL
  • e. <6 ng/mL

6. True statements regarding cytomegalovirus infection include all of the following except

  • a. Prophylactic intravenous ganciclovir is indicated for CMV donor-positive/recipient negative but not for CMV donor-negative/recipient-negative
  • b. Second-line treatments include foscarnet, acyclovir, and cidofovir
  • c. Genotypic testing for mutations can be done to determine if CMV is resistant to ganciclovir
  • d. Ganciclovir resistance should be considered in patients with rising CMV loads despite at least 14 days of therapy

7. Minimal recommended time for Pneumocystis jirovecii prophylaxis, according to the authors:

  • a. 0 months
  • b. 3 months
  • c. 6 months
  • d. 12 months
  • e. 3 years

Answers:

1. C, 2. D, 3. True, 4. A, 5. E, 6. B, 7. C

Related blog posts:

3 thoughts on “AASLD Guideline: Long-Term Care for Pediatric Liver Transplantation

  1. Pingback: Growth after Liver Transplantation | gutsandgrowth

  2. Pingback: AASLD/NASPGHAN 2014 Guidelines for Evaluation of Pediatric Liver Transplantation | gutsandgrowth

  3. Pingback: Subclinical Liver Transplant Rejection | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.